LDL-C Monitoring Frequency After the Diagnosis of Diabetes or Atherosclerotic Cardiovascular Disease

被引：0
|
作者：
Cohen, Sarah S.
Chamberlain, Alanna M.
Killian, Jill M.
Monda, Keri L.
Weston, Susan A.
Okerson, Ted
机构：
来源：
CIRCULATION | 2017年 / 136卷
关键词：
Statins; LDL; Epidemiology; Diabetes; Mellitus; Cardiovascular disease;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
15727
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Inclisiran: A New Strategy for LDL-C Lowering and Prevention of Atherosclerotic Cardiovascular Disease
    Albosta, Michael S.
    Grant, Jelani K.
    Taub, Pam
    Blumenthal, Roger S.
    Martin, Seth S.
    Michos, Erin
    VASCULAR HEALTH AND RISK MANAGEMENT, 2023, 19 : 421 - 431
  • [2] The importance of LDL-C lowering in atherosclerotic cardiovascular disease prevention: Lower for longer is better
    Mhaimeed, Omar
    Burney, Zain A.
    Schott, Stacey L.
    Kohli, Payal
    Marvel, Francoise A.
    Martin, Seth S.
    AMERICAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2024, 18
  • [3] Discordant LDL-C Estimates and Incident Atherosclerotic Cardiovascular Disease: The Dallas Heart Study
    Macpherson, Nicholas
    Vasquez, Nestor
    Khera, Amit
    Rohatgi, Anand
    Martin, Seth S.
    Jones, Steven R.
    Ayers, Colby
    Quispe, Renato
    Joshi, Parag H.
    Muthukumar, Alagarraju
    CIRCULATION, 2020, 142
  • [4] LP(A) DISTRIBUTION AND CORRELATION WITH LDL-C IN PATIENTS WITH ATHEROSCLEROTIC CARDIOVASCULAR DISEASE (ASCVD) IN THE US
    Lahoz, Raquel
    Laguna, Andres
    Ferber, Philippe
    Studer, Rachel
    Cristino, Joaquim
    Heo, Jihaeng
    Ding, Yingjie
    Fonseca, Ana Filipa
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (18) : 1563 - 1563
  • [5] The LDL-C/ApoB ratio predicts major cardiovascular events in patients with established atherosclerotic cardiovascular disease
    Drexel, Heinz
    Larcher, Barbara
    Mader, Arthur
    Vonbank, Alexander
    Heinzle, Christine F.
    Moser, Berthold
    Zanolin-Purin, Daniela
    Saely, Christoph H.
    ATHEROSCLEROSIS, 2021, 329 : 44 - 49
  • [6] Association of Ldl-c Level With Outcomes in Patients With Chronic Kidney Disease and no History of Atherosclerotic Cardiovascular Disease
    Mathew, Roy O.
    Sidhu, Mandeep S.
    Rangaswami, Janani
    Bangalore, Sripal
    CIRCULATION, 2019, 140
  • [7] LDL-C Lowering in Prevention of Atherosclerotic Cardiovascular Disease Another Step Forward in This Lifelong Marathon
    Nambi, Vijay
    Abushamat, Layla A.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (06) : 665 - 668
  • [8] Lifelong prevention of atherosclerotic cardiovascular disease (ASCVD) through LDL-C control - Means and cost/benefit of sustained very low lifetime LDL-C targets
    Dalakoti, Mayank
    Virani, Salim
    AMERICAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2024, 19
  • [9] Beyond LDL-C: unravelling the residual atherosclerotic cardiovascular disease risk landscape-focus on hypertriglyceridaemia
    Bashir, Bilal
    Schofield, Jonathan
    Downie, Paul
    France, Michael
    Ashcroft, Darren M.
    Wright, Alison K.
    Romeo, Stefano
    Gouni-Berthold, Ioanna
    Maan, Akhlaq
    Durrington, Paul N.
    Soran, Handrean
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2024, 11
  • [10] Lipoprotein(a) is a Determinant of Residual Cardiovascular Risk in the Setting of Optimal LDL-C in Statin-Treated Patients With Atherosclerotic Cardiovascular Disease
    Ruotolo, Giacomo
    Lincoff, Michael A.
    Menon, Venu
    McErlean, Ellen
    Wolski, Kathy
    Haas, Joseph V.
    Weerakkody, Govinda
    Riesmeyer, Jeffrey S.
    Nissen, Steven E.
    Nicholls, Stephen J.
    CIRCULATION, 2017, 136
12345